Literature DB >> 15131801

Chronic hepatitis C with normal aminotransferase levels.

Aijaz Ahmed1, Emmet B Keeffe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15131801     DOI: 10.1053/j.gastro.2004.02.073

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  10 in total

Review 1.  Peginterferon alpha-2a (40KD) plus ribavirin: a review of its use in the management of patients with chronic hepatitis C and persistently 'normal' ALT levels.

Authors:  Gillian M Keating; Greg L Plosker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Comparison of hepatitis C virus testing strategies: birth cohort versus elevated alanine aminotransferase levels.

Authors:  Bryce D Smith; Anthony K Yartel
Journal:  Am J Prev Med       Date:  2014-09       Impact factor: 5.043

3.  Incidence of hepatocellular carcinoma in HCV-infected patients with normal alanine aminotransferase levels categorized by Japanese treatment guidelines.

Authors:  Naoki Harada; Naoki Hiramatsu; Tsugiko Oze; Ryoko Yamada; Mika Kurokawa; Masanori Miyazaki; Takayuki Yakushijin; Takuya Miyagi; Tomohide Tatsumi; Shinichi Kiso; Tatsuya Kanto; Akinori Kasahara; Masahide Oshita; Eiji Mita; Hideki Hagiwara; Yoshiaki Inui; Kazuhiro Katayama; Shinji Tamura; Harumasa Yoshihara; Yasuharu Imai; Atsuo Inoue; Norio Hayashi; Tetsuo Takehara
Journal:  J Gastroenterol       Date:  2012-09-14       Impact factor: 7.527

4.  Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice.

Authors:  Norio Horiguchi; Fouad Lafdil; Andrew M Miller; Ogyi Park; Hua Wang; Mohanraj Rajesh; Partha Mukhopadhyay; Xin Yuan Fu; Pal Pacher; Bin Gao
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

5.  Management and treatment of hepatitis C virus in patients with HIV and hepatitis C virus coinfection: A practical guide for health care professionals.

Authors:  Pierre Côté; Jean-Guy Baril; Marie-Nicole Hébert; Marina Klein; Richard Lalonde; Marc Poliquin; Danielle Rouleau; Rachel Therrien; Sylvie Vézina; Bernard Willems; Harold Dion; Patrice Junod; Normand Lapointe; Dominic Lévesque; Lyse Pinault; Cécile Tremblay; Benoît Trottier; Sylvie Trottier; Chris Tsoukas; Alain Piché
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-09       Impact factor: 2.471

6.  Disease progression in chronic hepatitis C patients with normal alanine aminotransferase levels.

Authors:  Dong Hyun Sinn; Geum-Youn Gwak; Jae-Uk Shin; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

7.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

8.  Current Treatment for Chronic Hepatitis C.

Authors:  Peter Ferenci
Journal:  Curr Treat Options Gastroenterol       Date:  2004-12

9.  Hepatitis C Is Poorly Associated With Drug Use in Cambodian Americans in Lowell, Massachusetts.

Authors:  Catherine Yu; Allen L Gifford; Cindy L Christiansen; Mari-Lynn Drainoni
Journal:  Open Forum Infect Dis       Date:  2016-05-12       Impact factor: 3.835

10.  Inhibitory Effect of 1-O-Hexyl-2,3,5-Trimethylhydroquinone on Dimethylnitrosamine-induced Liver Fibrosis in Male SD Rats.

Authors:  Yu-Ri Jung; Young-Jung Lee; Nam-Jin Lee; Chun-Mai Lin; Jun-Hawn Moon; Hee-Yul Chai; Jong-Koo Kang
Journal:  Toxicol Res       Date:  2010-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.